Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
concettaelisa.onesti@uniroma1.it
Concetta Elisa Onesti
Lavoratore autonomo
Struttura:
DIPARTIMENTO DI SCIENZE ANATOMICHE, ISTOLOGICHE, MEDICO LEGALI E DELL'APPARATO LOCOMOTORE
E-mail:
concettaelisa.onesti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study
FRONTIERS IN PSYCHOLOGY
2023
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice
ANALYTICAL CELLULAR PATHOLOGY
2018
Hyperprogressive disease and early hypereosinophilia after anti-PD-1 treatment. a case report
DRUG SAFETY - CASE REPORTS
2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival
MEDICAL ONCOLOGY
2018
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes
ANTICANCER RESEARCH
2017
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient
ANTI-CANCER DRUGS
2017
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong
JOURNAL OF THORACIC DISEASE
2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients
JOURNAL OF CLINICAL ONCOLOGY
2017
Evolving treatments for advanced gastric cancer: appraisal of the survival trend
EXPERT REVIEW OF ANTICANCER THERAPY
2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer
ANTI-CANCER DRUGS
2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?
PLOS ONE
2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
ANTI-CANCER DRUGS
2016
A rare case of palatin tonsillar metastasis from small cell lung cancer
TRANSLATIONAL LUNG CANCER RESEARCH
2016
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
DIGESTIVE AND LIVER DISEASE
2016
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: A single-center experience and review of the literature
TRANSLATIONAL LUNG CANCER RESEARCH
2016
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
MEDICAL ONCOLOGY
2015
Genetic polymorphism can help physician choosing the best lung cancer chemotherapy
ANNALS OF ONCOLOGY
2015
What to expect from high throughput genomics in metastatic breast cancers?
THE BREAST
2015
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
ANTI-CANCER DRUGS
2015
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma